{"created":"2023-05-15T15:27:58.839146+00:00","id":17006,"links":{},"metadata":{"_buckets":{"deposit":"27ff66e7-984d-4e9e-96e3-0d2ae497a60a"},"_deposit":{"created_by":3,"id":"17006","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"17006"},"status":"published"},"_oai":{"id":"oai:sucra.repo.nii.ac.jp:00017006","sets":["85:358:394"]},"author_link":["27704"],"item_120_alternative_title_1":{"attribute_name":"タイトル（別言語）","attribute_value_mlt":[{"subitem_alternative_title":"Profitability Analysis of Japanese Pharmaceutical Companies : Comparative Study on Takeda Pharmaceutical and Chugai Pharmaceutical"}]},"item_120_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2013","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"86","bibliographicPageStart":"61","bibliographicVolumeNumber":"140","bibliographic_titles":[{"bibliographic_title":"社会科学論集"},{"bibliographic_title":"SHAKAIKAGAKU－RONSHU (The Social Science Review)","bibliographic_titleLang":"en"}]}]},"item_120_date_31":{"attribute_name":"作成日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2013-12-09","subitem_date_issued_type":"Created"}]},"item_120_description_19":{"attribute_name":"概要","attribute_value_mlt":[{"subitem_description":"The Japanese government suggests that the health industry is a growing industry.\nIn particular, pharmaceutical and medical equipment industries are significant sectors of the health industry.\nThe author agrees, but can Japanese pharmaceutical companies compete? This paper looks at two companies (Takeda Pharmaceutical Co., Ltd. and Chugai Pharmaceutical Co., Ltd.) and examines their profitability between 2004 and 2011. The paper focuses on management capital which is a value driver of total capital. The findings are as follows.\nTakeda is based on small molecule drugs which are not related to unmet medical needs. As a result, the Rate of Return on Assets (ROA) for Takeda is in an alarming decline.\nOn the other hand, Chugai is based on big molecule drugs which are related to unmet medical needs. Chugai is under the control of F. Hoffman-La Roche Ltd., and it introduces bio drugs. Therefore, the ROA for Chugai has been constant for 8 years.\nWhy is the Takeda ROA in decline? This paper researches the factor of profitability (profitability analysis).\nIn Takeda, both the ratio of profit to net sales and the rate of management capital turnover are in decline. Takeda has not developed new innovative drugs. In the case of Chugai, not only the ratio of profit to net sales but also the rate of management capital turnover are generally constant because Chugai introduces bio drugs through the Roche group.\nIn the future, the success of the two companies depends on their R&D capability to develop innovative drugs.","subitem_description_type":"Other"}]},"item_120_description_20":{"attribute_name":"目次","attribute_value_mlt":[{"subitem_description":"1．本研究の課題と方法\n2．医薬品企業の収益モデル\n3．医薬品企業における「収益性の分析」\n4．研究開発と収益性\n5．結論","subitem_description_type":"Other"}]},"item_120_description_29":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_120_description_30":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_120_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24561/00017000","subitem_identifier_reg_type":"JaLC"}]},"item_120_publisher_11":{"attribute_name":"出版者名","attribute_value_mlt":[{"subitem_publisher":"埼玉大学経済学会"}]},"item_120_publisher_12":{"attribute_name":"出版者名（別言語）","attribute_value_mlt":[{"subitem_publisher":"The Economics Society of Saitama University"}]},"item_120_source_id_14":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"05597056","subitem_source_identifier_type":"ISSN"}]},"item_120_text_27":{"attribute_name":"版","attribute_value_mlt":[{"subitem_text_value":"[出版社版]"}]},"item_120_text_3":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"KANEKO, Shigeru"}]},"item_120_text_32":{"attribute_name":"アイテムID","attribute_value_mlt":[{"subitem_text_value":"KY-AN00109186-140-08"}]},"item_120_text_4":{"attribute_name":"著者 所属","attribute_value_mlt":[{"subitem_text_value":"埼玉大学経済学部"}]},"item_120_text_5":{"attribute_name":"著者 所属(別言語)","attribute_value_mlt":[{"subitem_text_value":"Faculty of Economics, Saitama University"}]},"item_120_text_9":{"attribute_name":"年月次","attribute_value_mlt":[{"subitem_text_value":"2013-11"}]},"item_120_version_type_28":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"金子, 秀"},{"creatorName":"カネコ, シゲル","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"27704","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"dfPmFSBx","nameIdentifierScheme":"研究者総覧","nameIdentifierURI":"http://s-read.saitama-u.ac.jp/researchers/pages/researcher/dfPmFSBx"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-01-24"}],"displaytype":"detail","filename":"KY-AN00109186-140-08.pdf","filesize":[{"value":"2.9 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"KY-AN00109186-140-08.pdf","url":"https://sucra.repo.nii.ac.jp/record/17006/files/KY-AN00109186-140-08.pdf"},"version_id":"8417cdce-05bc-4107-bea9-cd999a9443ed"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"profitability analysis","subitem_subject_scheme":"Other"},{"subitem_subject":"management capital","subitem_subject_scheme":"Other"},{"subitem_subject":"ratio of profit to net sales","subitem_subject_scheme":"Other"},{"subitem_subject":"rate of management capital turnover","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》"}]},"item_type_id":"120","owner":"3","path":["394"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-12-10"},"publish_date":"2013-12-10","publish_status":"0","recid":"17006","relation_version_is_last":true,"title":["医薬品企業の収益性に関する一考察 : 武田薬品工業と中外製薬の比較研究《研究ノート》"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-05-15T18:32:57.085810+00:00"}